AGER and medical procedure: By monitoring serum EN-RAGE, sRAGE, EN-RAGE/sRAGE value and clinical parameters for these patients, we found that posttreatment group showed a striking reduction of ALT and AST but improved level of ALB, implying that there is a mitigation of liver damage and recovery of liver functions.